SCHEMBL932487

SCHEMBL932487

CC1=NC(c2cc(NC(=O)c3ccc(Cl)cn3)ccc2F)(C2CC2)N=C1N

nearest known ligand 0.60

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 19/20 0.60
APP P05067 2/20 0.59
BACE2 Q9Y5Z0 2/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18926487 0.86 BACE1 (0.65) BACE1APP
SCHEMBL931202 0.85 BACE1 (0.59) BACE1APPBACE2
SCHEMBL21654466 0.79 BACE1 (0.66) BACE1APPBACE2
SCHEMBL1173053 0.77 BACE1 (0.79) BACE1APPBACE2
SCHEMBL18927139 0.77 BACE1 (0.67) BACE1APPBACE2
SCHEMBL20628895 0.76 BACE1 (0.75) BACE1BACE2
SCHEMBL18926394 0.75 BACE1 (0.66) BACE1APPBACE2
SCHEMBL2582451 0.75 BACE1 (1.00) BACE1BACE2
SCHEMBL14551021 0.75 BACE1 (1.00) BACE1BACE2
SCHEMBL7707681 0.75 BACE1 (1.00) BACE1BACE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO claimed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed